Scharlab,S.L.

Headquartered in Barcelona (Spain), Scharlab has experienced an outstanding growth in the last few decades. This has led us to establish subsidiaries in 5 countries and enabled us to develop a presence worldwide through a distribution network that covers over 100 countries. The company was founded in 1949 in Barcelona under the name of F.E.R.O.S.A. as a company to synthesise organic compounds. In 1954 this company was bought over by Paul Scharlau, a second generation German in Spain. He then came to an agreement with the German company Dr. Theodor Schuchardt to distribute their laboratory chemicals and to manufacture in Spain under licence. In 1970, Schuchardt, was sold to Merck-Darmstadt and FEROSA had no alternative but to start selling chemicals under a different name and thus the Scharlau brand was born in 1971. Thousands of purification processes were consequently perfected to offer reagents of exceptional purity.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

Chemical Fuels in a Carbon Neutral Energy System

Webinar

2nd Global Conference on Advances in Polymer Science and Nanotechnology

Conference

The 2nd International Conference on Negative CO2 Emissions

Conference

22nd Tetrahedron Symposium Catalysis for a Sustainable World

Conference

Exploring Fluxes, Forms and Origins of Deep Carbon in Earth and Other Terrestrial Planets

Conference

2022 Ethylene Middle East Technology Conference (EMET)

Conference

Related News

ST. LUKE'S CONTRIBUTES TO RESEARCH ON MONOCLONAL ANTIBODIES MADE FAMOUS BY PRESIDENT TRUMP'S TREATMENT

Prnewswire | October 09, 2020

Patients who recovered from COVID-19 at St. Luke's University Health Network have donated their antibody-rich blood to medical science in hopes of helping to find an effective treatment or cure to the novel coronavirus that has killed nearly 200,000 Americans. The "convalescent plasma" was separated from the survivors' blood and is being studied as part of a research project labeled AR-701, sponsored by Aridis Pharmaceuticals, a biopharmaceutical firm in San Jose, Ca., th...

CHEMICAL MANAGEMENT

CARBON STREAMING PROVIDES INVESTMENT PIPELINE AND CORPORATE UPDATE

Carbon Streaming | April 25, 2022

Carbon Streaming Corporation is pleased to provide an update on its investment pipeline as the Company continues to build a diversified portfolio of high-quality carbon streaming investments around the globe. Indonesia Update The Indonesian government has temporarily paused validation of carbon credits from projects on the Verra Registry as it seeks to finalize its national carbon policy. The Company maintains a carbon stream investment in the Rimba Raya Bi...

PU: AMERICAN PLANTS RUNNING AT REDUCED RATES IN SECOND QUARTER

Bicmagazine | June 01, 2020

The running rates reduction comes amid a sharp decline in resin prices like polyethylene (PE). Experts believe the ongoing weakness may linger for an undetermined period, as reported by Petrochemical Update. Petrochemical plants in the Americas are running at reduced rates, or in some cases idled, to try to balance out the erosion of downstream resin consumption caused by the Covid-19 pandemic. Domestic prices for resins have declined and export markets for North American resin have contracted. ...

CHEMICAL MANAGEMENT

INVERT ADDS FURTHER CARBON CREDIT EXPERIENCE AND LEADERSHIP TO TEAM

Invert Inc. | March 04, 2022

Invert Inc. a specialized carbon emissions reduction and offsetting company, is pleased to announce that it has expanded its team to add new carbon project expertise and IT development leadership. Joining the team as Head of Carbon Forestry is Matt Delaney. Matt is a forester specializing in carbon projects and has over 20 years of experience in forest carbon methodology development, forest inventory techniques, and carbon markets. He has been part of the successful implementation...